Search results

Found 185 pages for ""
AUTHOR: John Pinching

Results per page

10 20 50 100

Sort by

Relevance Date

24 Jun 2022:

Positive MHRA decision for Briviact

MHRA extends UCB’s therapy for the treatment of partial-onset seizures - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/positive_mhra_decision_for_briviact_1450496

23 Jun 2022:

Pharma poised but no recorded monkeypox deaths

Global surveillance systems show that recorded cases do not include any deaths - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/pharma_poised_but_no_recorded_monkeypox_deaths_1450379

27 Jun 2022:

AbbVie’s Rinvoq gains recommended approval by CHMP

CHMP returns positive opinion on Rinvoq for the treatment of adults with active non-radiographic axial spondyloarthritis - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/abbvies_rinvoq_gains_recommended_approval_by_chmp_1450589

27 Jun 2022:

EU approves Norvatis’ Cosentyx for childhood arthritis

Cosentyx receives expanded approvals in EU for use in childhood arthritic conditions - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/eu_approves_norvatis_cosentyx_for_childhood_arthritis_1450588

22 Jun 2022:

NICE opts to reject Acorda’s MS drug Fampyra

The MS Society responds as MS therapy Fampyra is rejected - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/nice_opts_to_reject_acordas_ms_drug_fampyra_1450334

22 Jun 2022:

Novartis lung cancer drug Tabrecta gets approval

Novartis receives approval from the European Commission for Tabrecta for the treatment of non-small cell lung cancer - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/novartis_lung_cancer_drug_tabrecta_gets_approval_1450335

24 Jun 2022:

Sanofi and GSK report successful efficacy results against Omicron

COVID-19 Beta-containing vaccine provides 75.1% efficacy in participants previously infected with coronavirus - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/sanofi_and_gsk_report_successful_efficacy_results_against_omicron_1450497

3 Jun 2020:

A whole new world

A whole new world - - Business Insights - PharmaTimes

by John Pinching|John Pinching

https://www.pharmatimes.com/business_insights/2020/a_whole_new_world

16 Jun 2022:

Nordic Bioscience and Roche strengthen collaboration

The companies will focus on the development of biomarkers for chronic diseases - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/nordic_bioscience_and_roche_strengthen_collaboration_1450086

15 Jun 2022:

Keensight Capital invests in AstraZeneca spin-out

The deal will boost CatSci’s ability to deliver best-in-class medicines to patients worldwide - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/keensight_capital_invests_in_astrazeneca_spin-out_1449985